| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $263.50M | $164.07M | $1.19M | – | – |
| Cost of Revenue | $173.18M | $124.00M | $10.76M | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | $398.88M | $342.70M |
| R&D | $300.27M | $282.34M | $344.08M | $294.78M | $259.04M |
| SG&A | $152.32M | $153.02M | $106.92M | $104.10M | $83.66M |
| Operating Income | -$403.36M | -$395.28M | -$460.56M | -$398.88M | -$342.70M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$2.07M | -$2.83M | -$3.48M | $0.00 | $0.00 |
| Net Income | -$390.98M | -$372.18M | -$444.04M | -$395.89M | -$342.25M |
| EPS (basic) | -1.0900 | -1.2800 | -1.8900 | -2.4900 | -2.2300 |
| EPS (diluted) | -1.0900 | -1.2800 | -1.8900 | -2.4900 | -2.2300 |
| Shares (diluted) | $357.35K | $289.88K | $235.13K | $159.26K | $153.41K |